ASIC3 and arthritic joint disease: Consistent with a decrease in arthritis scores, the severity of synovial inflammation, bone destruction, and cartilage damage was attenuated in ASIC3−/− mice from 4 weeks (Fig. 3G–J), except that synovial inflammation and cartilage damage were not significantly reduced at 12 weeks (Fig. 3H,J).